Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Express Scripts
Baxter
Moodys
McKinsey

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Drug Price Trends for EFAVIRENZ

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Drug Price Trends for EFAVIRENZ

Average Pharmacy Cost for EFAVIRENZ

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
EFAVIRENZ 600 MG TABLET 65862-0774-30 11.16166 EACH 2019-11-20
EFAVIRENZ 600 MG TABLET 00378-2233-93 11.16166 EACH 2019-11-20
EFAVIRENZ 600 MG TABLET 64380-0889-04 11.16166 EACH 2019-11-20
EFAVIRENZ 600 MG TABLET 69097-0301-02 11.16166 EACH 2019-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for EFAVIRENZ

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
SUSTIVA 200MG CAP Bristol-Myers Squibb Company 00056-0474-92 90 985.55 10.95056 EACH 2020-01-01 - 2023-04-30 FSS
SUSTIVA 50MG CAP Bristol-Myers Squibb Company 00056-0470-30 30 82.18 2.73933 EACH 2018-05-01 - 2023-04-30 FSS
SUSTIVA 600MG TAB Bristol-Myers Squibb Company 00056-0510-30 30 684.06 22.80200 EACH 2018-05-01 - 2023-04-30 Big4
SUSTIVA 50MG CAP Bristol-Myers Squibb Company 00056-0470-30 30 61.21 2.04033 EACH 2019-01-01 - 2023-04-30 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Boehringer Ingelheim
Express Scripts
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.